Non-Communicable Diseases and Cancer
Cancer prevalence and mortality rates are on the increase globally. Among the many factors that cause cancer, oxidative stress is one of the key important and well-studied events that give rise to the conditions leading to tumor onset and progression.
With the improvement of cancer therapeutics, the proportion of cancer patients who survive for more than five years after diagnosis has increased. Nevertheless, cancer therapeutics that are available, such as surgery, chemotherapy, and radiotherapy are often associated with adverse side effects and significant morbidity. Incorporating complementary and alternative therapies into conventional cancer treatment could potentially reduce the side effects.
Vernonia amygdalina - The Power of Bitter Leaf
Vernonia amygdalina (Bitter Leaf)
A plant used in African traditional medicine, native to Nigeria. Leaf extracts of VA have been found to possess antioxidant, antibacterial, anti-inflammatory, anti-parasitic, and anti-cancer activities. Plant and spices used in traditional medicine are one of the main sources in the discovery and development of prophylactic and chemo-preventive drugs. They have been known to have valuable properties ranging from antioxidant, anti-bacterial, anti-inflammatory, hepatoprotective, and anti-carcinogenic activities.
Oxidative Stress and Cancer: Oxidative stress often causes chronic inflammation, which might lead to cancer. The antioxidant compounds in Roveda can defend the body by scavenging free radicals and thus normalizing the oxidative state. This proves to be helpful in the prevention of cancer.
Prostate Tumours
Prostate cancer is the most common noncutaneous cancer and second leading cause of cancer-related death in North American males. Worldwide, prostate cancer-related deaths represent the sixth leading cause of death among men. Although cancer therapy in the form of surgery or radiotherapy is effective when the disease is detected early, many cancers are still diagnosed when cells from a primary tumor have already metastasized.
The main form of treatment at this point is chemotherapy, which consists of delivering drugs systemically to kill the tumor cells. However, several chemotherapeutic agents cause severe side effects. The low efficacy of chemotherapy in patients with advanced cancers is reflected by the low 5-year survival rates observed.
Breast Tumours
Breast cancer is the commonest type of cancer in women, with an alarmingly increasing incidence in developed and developing countries. It is the first and fifth commonest cause of cancer deaths in women and both sexes respectively.
50%
Estimated reduction in breast cancer
occurrence by preventing obesity
2/3
Of
breast cancer cases are hormone receptor-positive
Breast cancer in humans is treated based on the receptor status of the tumour. Hormone receptor-positive breast cancers are positive for the Oestrogen receptor (ER) and/or Progesterone receptor (PR), thus needing oestrogen and progesterone respectively to grow and spread.
Benign Prostate Hyperplasia (BPH)
BPH and prostate cancer are leading causes of urologic problems in older men. Both conditions share certain attributes in common. They are hormone and age dependent. Risk increases with age, and they are associated with certain forms of hyperplasia. Roveda is useful in managing benign prostate hypertrophy.
Effect of Roveda on Tumours
Roveda is rich in biologically active compounds such as antioxidants and polyphenols. These compounds are known to be protective against tumours. Evidence shows that Roveda retards cancer cell proliferation in a concentration- and time-dependent manner. The retardation took place via DNA synthesis inhibition and DNA damage. This can be interpreted as anti-cancer activity as DNA synthesis is required for cell growth.
Roveda May Help Suppress, Delay, or Kill Cancerous Cells Through:
- Induction of apoptosis (death of tumour cell)
- Enhanced Chemotherapy Sensitivity - render cancerous cells to be more sensitive to chemotherapy
- Inhibition of the growth or growth signals of cancerous cells
- Suppression of metastasis (spread) of cancerous cells in the body by the inhibition of NFκB
- Reduction of estrogen level in the body by the suppression of Aromatase activity
Prostate Cancer
Roveda reduces growth of prostate cancer cells and is useful in managing benign prostate hypertrophy. It may be used alone or in combination (adjuvant) with known drugs.
Breast Cancer
Roveda potently retards the proliferative activities of ER+ human breast cancerous cells (MCF-7) in a concentration- dependent fashion. It may be used alone or as an adjuvant therapy.
Obesity and Breast Cancer Connection: Researchers have estimated that preventing obesity reduces the occurrence of breast cancer by 50%. Roveda's antioxidant properties support overall metabolic health.
Why Roveda Should Be Your Option
Use daily to prevent tumours, especially if any of your close relatives has had cancer. Roveda offers natural chemopreventive support with minimal side effects.
- Roveda 600mg at the dose of 1 or 2 capsules once a day prevents tumours
- It reduces growth of prostate cancer cells
- It reduces growth of breast cancer cells
- It is useful in managing benign prostate hypertrophy
- It can be used as adjunct in managing these tumours
- It is a very strong antioxidant
- Supports overall cellular health
- Natural, safe, and virtually without side effects
Dosage
Recommended Dosage: 1 to 2 capsules once daily.
Administration: Take with water, preferably with meals. For best results, use consistently as part of a healthy lifestyle.
Key Benefits Summary
- Potent antioxidant activity protects against oxidative stress
- Retards cancer cell proliferation via DNA synthesis inhibition
- Induces apoptosis in tumour cells
- Suppresses metastasis through NFκB inhibition
- Reduces estrogen levels by suppressing aromatase activity
- Supports prostate health and manages BPH
- Supports breast health in ER+ breast cancer
- Enhances chemotherapy sensitivity
Complementary and Alternative Therapy
Incorporating complementary and alternative therapies into conventional cancer treatment could potentially reduce side effects associated with surgery, chemotherapy, and radiotherapy. Roveda, derived from Vernonia amygdalina, offers a natural, relatively inexpensive, non-toxic, chemopreventive option that can be used alongside conventional treatments.
Roveda 600 - Nature's Support for Cellular Health